Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

Novel cancer vaccine plus pembrolizumab prolongs PFS in advanced melanoma
11 Jul 2026
bởiStephen Padilla
An investigational, immune-modulatory cancer vaccine, IO102-IO103, when combined with pembrolizumab results in sustained progression-free survival (PFS) compared with pembrolizumab alone in patients with advanced melanoma, reports a study.








